FBXW7-AS1 and neutropenia: Reporting the identification of the DEspR+neutrophil subset with capacity to form and release NETs while still in the circulation and in the presence of relative neutropenia as side effect of DMARD therapy is important and provides insight into why RA-flares may occur despite maintenance therapy.